Radiopharm Theranostics announces annual general meeting
RAD•Radiopharm Theranostics will hold a virtual annual general meeting on November 25, 2026. Shareholders will consider additional equity issuance capacity of 10% of issued capital over 12 months and renewal of an incentive plan allowing up to 471,088,279 securities to be issued over three years.
1. Meeting and resolutions
Radiopharm Theranostics will hold its annual general meeting virtually through the Automic Investor Portal on November 25, 2026. Resolutions also cover adoption of the remuneration report and Bruce Goodwin's election as a director.
